Second Annual Washington University Glomerular Disease Symposium: An Update on Disease Mechanisms and Management a Success (Links to an external site)

Tingting Li, MD, MSCI,

Kudos to everyone who helped make the 2nd Annual Glomerular Disease Symposium: An Update on Disease Mechanisms and Management, held September 6 – 7, 2024, a success.  The event was organized and chaired by WashU Nephrology’s Tingting Li, MD, MSCI, with the support of the planning committee members Michelle Bloom, BSN, RN, Reena Gurung, MD, Nidia Messias, MD, and Morgan Schoer, MD, and Continuing Medical […]

Odeny publication in Science Direct offers new cancer insights

Crucial intersection of oncology and HIV research, with insights for clinical practice Thomas A. Odeny, MD, MPH, PhD, Assistant Professor of Medicine at WashU Division of Medical Oncology, leads the Global Oncology Initiative. He recently was published in Science Direct with new insights into HIV and cancer research. Dr. Odeny’s research focuses on applying implementation […]

WashU Fellow Published in Annual Reviews

Giulia Petrone, MD

Giulia Petrone, MD, WashU Hematology/Oncology Fellow, study, “Clinical and Therapeutic Implications of Clonal Hematopoisis” was recently published in Annual Review of Genomics and Human Genetics, Volume 25, 2024. Clonal Hematopoiesis (CH) is a condition in which hematopoietic stem and progenitor cells acquire the same somatic mutations, leading to the expansion of these mutated cells. The […]

Study shows novel low-dose 3-in-1 blood pressure pill outperforms standard care

Mark Huffman, MD

Over 80% of patients achieved control within a month, sustained at six months A new study, that Mark Huffman, MD, MPH, William Bowen Professor of Medicine, Co-Director, Global Health Center, WashU Cardiovascular Division, who is a co-author, shows that a treatment plan containing low doses of three antihypertensive drugs in a single pill – known […]

Ferraro lab publishes Acute Myeloid Leukemiain Research in AACR

Francesca Ferraro, MD, PhD

The Ferraro Lab led by Francesca Ferraro, MD, PhD, Assistant Professor of Medicine, WashU Division of Oncology has recently made significant contribution in understanding the role of MYC mutations in the development of Acute Myeloid Leukemia (AML). Dr. Ferraro’s lab publication, titled “Missense Mutations in Myc Box I Influence Nucleocytoplasmic Transport to Promote Leukemogenesis,” is […]

Study reveals how brain cancer evolves in response to treatment  (Links to an external site)

cancer cell graphic

Researchers at Washington University School of Medicine in St. Louis have shown how brain tumors evolve in response to therapy, helping describe how such cancers develop treatment resistance that leads to the high mortality rate characteristic of this cancer. Only 5% of patients survive five years after diagnosis with the most aggressive brain cancers.  

DNA fragments help detect kidney organ rejection  (Links to an external site)

Tarek Alhamad, MD, MS

Raja Dandamudi, MD, an assistant professor of pediatrics, Vikas Dharnidharka, MD, a professor of pediatrics, and Tarek Alhamad, MD, a professor of medicine at Washington University School of Medicine in St. Louis, contributed to a large study that identified a novel way of detecting signs of organ rejection. The international team found that DNA shed from dying […]

Meet the Researcher: Marlie Maestas  (Links to an external site)

Marlie Maestas

Marlie Maestas, a fifth-year graduate student in the Millman Lab, recently published her first first-authorship in Nature Communications. The study, titled Identification of unique cell type responses in pancreatic islets to stress, detailed the responses of different pancreatic islet cell types to endoplasmic reticulum and inflammatory stress.

Anuja Java Published in Science Direct

Anuja Java, MD

Anuja Java, MD, Associate Professor of Medicine, Director, Kidney Transplant John Cochran VA Medical Center, Division of Nephrology, Washington University School of Medicine recently had two articles published in Science Direct. Thrombotic Microangiopathies and the Kidney Both articles delve into defining current understanding of the pathophysiological mechanisms underlying Thrombotic Microangiopathies (TMAs). TMA is a multisystem […]

Heme-Onc Fellow Cochran published in Leukemia & Lymphoma

Hunter Cassidy Cochran, MD

Pretransplant desensitization of donor-specific anti-HLA antibodies with plasmapheresis and immunoglobulin produces equivalent outcomes to patients with no donor specific antibodies in haploidentical hematopoietic cell transplant Hunter Cassidy Cochran, MD, Hematology-Oncology Fellow, was recently published in Leukemia & Lymphoma. In many hematologic malignancies, hematopoietic cell transplant (HCT) is the only curative option. The likelihood of finding […]

DOLF Initiating a Follow Up Study on Moxidectin plus Albendazole (MoxA) Combination Treatment for Lymphatic Filariasis and Onchocerciasis in Cote d’Ivoire (Links to an external site)

Members of the DOLF team looking for microfilariae in samples

DOLF investigators are beginning a follow-up study on the efficacy of a new combination treatment for lymphatic filariasis (LF) and onchocerciasis in the Akoupé district of Côte d’Ivoire. This study began July 4th and builds upon a large-scale community survey sponsored by Medicines Development for Global Health (MDGH).

DOM researchers publish in Science Immunology

Researchers in the Department of Medicine reveal new ways that human natural killer (NK) cells are rewired by signals through cytokine receptors to generate a memory-like program.  In a report published in Science Immunology, co-first authors Jennifer Foltz, PhD, and Jennifer Tran build on prior work from senior author Todd Fehniger, MD, PhD, WashU Division […]

Kulkarni Editorial Published in Journal of Clinical Investigation

Hrishikesh S. Kulkarni, MD

“Hexamerization: explaining the original sin of IgG-mediated complement activation in acute lung injury” Hrishikesh S Kulkarni, MD, MSCI, Associate Professor of Medicine and Molecular Microbiology; Associate Program Director for Research, Division of Pulmonary and Critical Care Medicine, recently was published in the Journal of Clinical Investigation (JCI). The editorial in the Journal of Clinical Investigation […]

Hughes Lab publication highlighted in Science Snapshot

Researchers used scanning electron microscopy to image the cytoskeletal components of the human pancreatic primary cilia.

Three dimensional images of human pancreatic islet cells provide an unprecedented view of the enigmatic primary cilia Jing Hughes, MD, Assistant Professor of Medicine, Division of Endocrinology, Metabolism & Lipid Research recent paper, “Scanning electron microscopy of human islet cilia” was published in Proceedings of the National Academy of Sciences (PNAS) and follow-up article, “Immuno-scanning […]

Outcomes of Hematology/Oncology Clinical Trials Development Program Published by Co-Chief Fellow Christine Auberle (Links to an external site)

Christine Auberle, MD

“Integration of Clinical Trial Development in Hematology-Oncology Fellowship Training” describes the Clinical Trial Development Program initiated at Washington University School of Medicine in 2002. This program was developed as a hands-on learning experience for Hematology-Oncology fellow in the design, implementation and publication of clinical trials and is led by Dr. Lee Ratner, Associate Program Director […]

Petersen study of cardiometabolic health in obesity published in Cell Metabolism

Max Peterson, MD, PhD

Max Petersen, MD, PhD, Instructor in Medicine, Division of Endocrinology, Metabolism & Lipid Research, recently published a paper, Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity, in Cell Metabolism. The senior author of the study was Samuel Klein, MD, the William Danforth Professor of Medicine, and Chief of the Division of Nutritional Science & […]

Disrupting Type One Diabetes

Jeffrey Millman, PhD

(interview with Dr. Jeff Millman) Tell Us About Yourself My name is Jeff Millman, PhD, and I am a bioengineer within the Division of Endocrinology, Metabolism and Lipid Research in the Department of Medicine here at WashU. My bioengineering expertise uniquely positions me to pioneer research in a laboratory environment, with a steadfast commitment to […]

Dr. Jeffrey Miner’s Research Group Lands KI Journal Cover (Links to an external site)

Jeffrey H. Miner, PhD, FASN

Congratulations to the research group headed by Jeffrey Miner, PhD, on their recent publication that landed the cover of Kidney International.  The colorful cover photograph, illustrating paraffin immunofluorescence of different collagen IV chains, is a figure from their article “Quantitative assessment of glomerular basement membrane (GBM) collagen IV α chains in paraffin sections from patients with focal segmental glomerulosclerosis […]

High-Dimensional Analyses Reveal IL-15 Enhances Prostate Cancer Immunotherapy

Russell Pachynski, MD

Prostate cancer cellular immunotherapy Russell Pachynski, MD, Associate Professor of Medicine, Division of Oncology, Director of Genitourinary (GU) Oncology Research, Washington University School of Medicine in St. Louis, published a paper in Cancer Immunology Research (“High dimensional analyses reveal activation of lymphocyte subsets and reversal of immunoresistance by cytokine-enhanced cellular vaccine therapy in prostate cancer”) […]

HIV Clinicians Represent Critical Point of Access for Treatment of Substance Use

Aditi Ramakrishnan, MD

Aditi Ramakrishnan, MD MSc, Assistant Professor in the Division of Infectious Diseases and Department of Medicine at the Washington University in St. Louis School of Medicine, had a first-author publication in Journal of Acquired Immune Deficiency Syndrome (JAIDS), a premier infectious diseases journal, describing the substance use treatment engagement among women with HIV in the […]

Mbalaviele Lab Published in eLife (Links to an external site)

Mbalaviele Lab Published in eLife

The Mbalaviele lab and collaborators found that inflammasomes play a critical role in bone loss in mice caused by the chemotherapeutic drug, doxorubicin. This finding may inspire the development of a tailored adjuvant therapy that preserves the quality of this tissue in patients treated with this class of drugs.

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Thomas M. Maddox, MD

The document also strengthens advice regarding which medications should be started in all patients Thomas M. Maddox, MD, MSc, Professor of Medicine in the Cardiovascular Division at WashU Medicine, and colleagues recently published an Expert Consensus Decision Pathway (ECDP) for the many decisions required in the management and treatment of patients with heart failure with […]

Scheller Lab and Colleagues Published in JCI Insight (Links to an external site)

Erica Scheller, DDS, PhD

Members of the Scheller Lab in collaboration with the Milbrandt and DiAntonio groups at WashU published a paper in JCI Insight in which they found that loss of Sarm1 could completely protect female mice against the development of bone loss and severe osteoblast suppression secondary to type 1 diabetes.